Blog
About

1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      A Clinician’s Viewpoint

      Cardiology

      S. Karger AG

      Cardiovascular disease, Costs, government intervention, Disease containment

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Most of the current generation of senior clinicians have been trained to put the interests and needs of the patient first. The doctor-patient relationship is sacrosanct, a binding contract to strive for the best in diagnosis and management, and it is ‘blind’ to cost. In monetary terms, present day diagnosis and treatment of cardiovascular disease are not cheap, although in this context many management strategies offer impressive improvements in quality and quantity of life. It is the high-profile nature of cardiovascular disease, its high cost, and its perception as a killer by the lay public that force government intervention. The political issues concerning government are: cost containment, maximizing returns for expenditure, and achieving socially acceptable levels of disease containment. To a lesser but nonetheless positive extent, government intervention may also drive clinical expansion and research in new areas, although it can be perceived as interference by a number of clinicians in the speciality.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          978-3-8055-6144-0
          978-3-318-01954-4
          0008-6312
          1421-9751
          1994
          1994
          18 November 2008
          : 85
          : Suppl 1
          : 113-117
          Affiliations
          Freeman Hospital, Newcastle upon Tyne, UK
          Article
          176773 Cardiology 1994;85(suppl 1):113-117
          10.1159/000176773
          7743528
          © 1994 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Categories
          Session IV: Government Intervention in Cardiovascular Disease – Help or Hindrance?

          Comments

          Comment on this article